Cullinan Oncology Statistics Share Statistics Cullinan Oncology has 59.01M
shares outstanding. The number of shares has increased by 1.79%
in one year.
Shares Outstanding 59.01M Shares Change (YoY) 1.79% Shares Change (QoQ) 0.86% Owned by Institutions (%) 99.99% Shares Floating 36.17M Failed to Deliver (FTD) Shares 2,000 FTD / Avg. Volume 0.55%
Short Selling Information The latest short interest is 5.88M, so 9.97% of the outstanding
shares have been sold short.
Short Interest 5.88M Short % of Shares Out 9.97% Short % of Float 11.54% Short Ratio (days to cover) 20.93
Valuation Ratios The PE ratio is -3.91 and the forward
PE ratio is -2.44.
Cullinan Oncology's PEG ratio is
0.25.
PE Ratio -3.91 Forward PE -2.44 PS Ratio 0 Forward PS 13.9 PB Ratio 1.11 P/FCF Ratio -4.51 PEG Ratio 0.25
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Cullinan Oncology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 13.53,
with a Debt / Equity ratio of 0.
Current Ratio 13.53 Quick Ratio 13.53 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.51M Employee Count 111 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 117K Effective Tax Rate -0.07%
Stock Price Statistics The stock price has increased by -56.5% in the
last 52 weeks. The beta is -0.07, so Cullinan Oncology's
price volatility has been lower than the market average.
Beta -0.07 52-Week Price Change -56.5% 50-Day Moving Average 8.08 200-Day Moving Average 9.91 Relative Strength Index (RSI) 41.25 Average Volume (20 Days) 361,941
Income Statement
Revenue n/a Gross Profit -306K Operating Income -196.92M Net Income -167.38M EBITDA -167.15M EBIT -167.46M Earnings Per Share (EPS) -3.11
Full Income Statement Balance Sheet The company has 83M in cash and 2.15M in
debt, giving a net cash position of 80.85M.
Cash & Cash Equivalents 83M Total Debt 2.15M Net Cash 80.85M Retained Earnings -368.24M Total Assets 579.68M Working Capital 290.42M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -145.3M
and capital expenditures 0, giving a free cash flow of -145.3M.
Operating Cash Flow -145.3M Capital Expenditures n/a Free Cash Flow -145.3M FCF Per Share -2.7
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
